Latest Breaking News On - Codexi codex hicap - Page 1 : comparemela.com

Codexis Reports Fourth Quarter and Fiscal Year 2023 Financial Results

28.02.2024 - Anticipate 2024 Product Revenue Growth of at Least 10% vs. 2023 Excluding Enzyme Sales Related to PAXLOVID Recently Announced Debt Financing Reinforces Strong Financial Position with Projected Runway Through Expected Positive Cash-flow Around End .

United statesJohn maraganoreDavid butlerLauren mustoCarrie mckimMasad damhaJim lalondeCodexis incSynthesis innovation labInnovatus capital partnersJames mcgill professor at universitySecurities exchangeExchange commissionHealth scienceAlnylam pharmaceuticalsHongene biotech corporation

Biggest stock movers today: Adobe, Ocular Therapeutix and more (NASDAQ:CDXS)

Biggest stock movers today: Adobe, Ocular Therapeutix and more (NASDAQ:CDXS)
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

United statesJohn hechtDanaher corpFederal reserveCodexi codex hicapExeter financeSubscription receipts

Codexis Shares Rise 19% on Licensing Agreement with Aldevron

By Denny Jacob Codexis shares were up 19% at $2.48 a day after it entered into an agreement with Aldevron. The stock is down about 47% on the year so far..

Denny jacobCodexi codex hicapCodex hicapArticle normalFinancial performanceShare price movement disruptionsCorporate industrial newsEquity marketsCommodity financial market newsContent typesFactiva filtersC amp ampe exclusion filterC amp ampe industry news filterShare price movementIndustrial newsFinancial market news